Ticker

No recent analyst price targets found for NIVF.

Latest News for NIVF

NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor

BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange…

GlobeNewsWire • Aug 17, 2026
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

NewGen's total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization NewGen's agreed 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai's recently closed Series A investment round, representing an unrealized gain of about US$8.5 million BANGKOK, July 30, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited…

GlobeNewsWire • Jul 30, 2026
NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million

K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen's 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million unrealized gain, expected to be booked in 2026 BANGKOK, July 23, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today…

GlobeNewsWire • Jul 23, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for NIVF.

No House trades found for NIVF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top